Optimum timing of lung resection surgery following SARS‐CoV‐2 infection for non‐small cell lung cancer
Abstract Background The impact of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection on postoperative recovery of non‐small cell lung cancer (NSCLC) is need to be understood, thereby informing the optimal timing of surgical decision‐making during the COVID‐19 pandemic for NSCLC p...
Main Authors: | Yanbo Yang, Lingli Niu, Yunke Zhu, Zhu Wu, Liang Xia, Congjia Xiao, Xu Shen, Xin Xiao, Conglin Tian, Feng Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6891 |
Similar Items
-
Gut-Lung Axis-A Compass to Navigate Microbiome Landscape in COVID-19
by: Arunava Kali, et al.
Published: (2023-11-01) -
Understanding the unusual viral outbreak: Coronavirus disease 2019
by: Tarun Kumar Suvvari, et al.
Published: (2020-01-01) -
Comparison of Six Immunoassays for Assaying Levels of Immunoglobulin G against the Nucleocapsid and Spike Proteins of SARS-CoV-2
by: Itsumi Suda, et al.
Published: (2022-07-01) -
Beyond the ventilator - cardiovascular management in SARS-CoV-2 infection
by: Amy L Kloosterboer, et al.
Published: (2021-01-01) -
Seroprevalence of severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibodies among health-care workers prior and after 4–6 weeks of coronavirus disease vaccine administration at tertiary care center of southwest Bihar, India
by: Mukesh Kumar, et al.
Published: (2022-01-01)